Clinical Oncology: Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Takashi Kangasand Daniel Saltzman (USA) Author

saltz002@umn.edu (612)626- 4214

Subjects of specialization
cancer, cancer oncology, Carcinogenesis

Affiliation
Department of Surgery, Division of Pediatric Surgery, University of Minnesota, Canada, U.S.A, Salspera LLC, Oakdale, MN, Canada, U.S.A.

Biography

Dr. Daniel Saltzman is working as scientist and professor at Department of Surgery, Division of Pediatric Surgery, University of Minnesota, Canada, U.S.A, Salspera LLC, Oakdale, MN, Canada, U.S.A. . The author has specalization in cancer, cancer oncology, chemotherapy, Carcinogenesis, Chemotherapy

Publications

Case Report Open Access

Orally Administered Multiple Dose Saltikva (Salmonella-IL2) in Conjunction with Folfirinox in a Patient with Stage IV Pancreatic Cancer: A Case Report

Author(s):

Gerald Batist, Joo Yeoun Park, Jeremy Drees, Takashi Kangas and Daniel Saltzman* (USA)

Compassionate use of Saltikva was sought for a patient with stage 4, metastatic pancreatic cancer. Approval was granted for an n=1 multiple dose (every 2 week) trial with concomitant FOLFIRINOX. Now, at 15 months, this patient has not experienced any toxicity to Saltikva, continues therapy, has normalized CA19-9 levels, maintained her immunologic cell populations despite cytotoxic chemotherapy, demonstrated a strong NK cell response, and has a radiologic regression of metastatic tumor burden with a complete absence of tumor activity by PET scan. 

... view more»

Abstract HTML PDF

Social Media

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP